Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yu Yumoto, Takuro Endo, Hiroshi Harada, Kaoru Kobayashi, Takeshi Nakabayashi & Yoshikazu Abe. (2024) High-throughput assay to simultaneously evaluate activation of CYP3A and the direct and time-dependent inhibition of CYP3A, CYP2C9, and CYP2D6 using liquid chromatography-tandem mass spectrometry. Xenobiotica 54:2, pages 45-56.
Read now
Read now
David F.V. Lewis, Brian G. Lake & Maurice Dickins. (2006) Quantitative structure–activity relationships (QSARs) in CYP3A4 inhibitors: The importance of lipophilic character and hydrogen bonding. Journal of Enzyme Inhibition and Medicinal Chemistry 21:2, pages 127-132.
Read now
Read now
David FV Lewis. (2005) Human P450s in the metabolism of drugs: molecular modelling of enzyme–substrate interactions. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 5-8.
Read now
Read now
Articles from other publishers (15)
Martiniano Bello, Jessica E. Mendieta-Wejebe & José Correa-Basurto. (2014) Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity. Biochemical Pharmacology 90:2, pages 145-158.
Crossref
Crossref
Joo Yun Lee, Nam Sook Kang & Young Kee Kang. (2011) Binding free energies of inhibitors to iron porphyrin complex as a model for Cytochrome P450. Biopolymers 97:4, pages 219-228.
Crossref
Crossref
Dmitri R. Davydov, Jessica A.O. Rumfeldt, Elena V. Sineva, Harshica Fernando, Nadezhda Y. Davydova & James R. Halpert. (2012) Peripheral Ligand-binding Site in Cytochrome P450 3A4 Located with Fluorescence Resonance Energy Transfer (FRET). Journal of Biological Chemistry 287:9, pages 6797-6809.
Crossref
Crossref
Chad D. Moore, Kiumars Shahrokh, Stephen F. Sontum, Thomas E. CheathamIIIIII & Garold S. Yost. (2010) Improved Cytochrome P450 3A4 Molecular Models Accurately Predict the Phe215 Requirement for Raloxifene Dehydrogenation Selectivity. Biochemistry 49:41, pages 9011-9019.
Crossref
Crossref
William J. Egan. 2010. Drug Design. Drug Design
165
178
.
Jaya S. Kartha, Konstantine W. Skordos, Hao Sun, Clifton Hall, LaHoma M. Easterwood, Christopher A. Reilly, Eric F. Johnson & Garold S. Yost. (2008) Single Mutations Change CYP2F3 From a Dehydrogenase of 3-Methylindole to an Oxygenase. Biochemistry 47:37, pages 9756-9770.
Crossref
Crossref
Jihoon Jung, Nam Doo Kim, Su Yeon Kim, Inhee Choi, Kwang-Hwi Cho, Won Seok Oh, Doo Nam Kim & Kyoung Tai No. (2008) Regioselectivity Prediction of CYP1A2-Mediated Phase I Metabolism. Journal of Chemical Information and Modeling 48:5, pages 1074-1080.
Crossref
Crossref
Nick Plant. (2007) The human cytochrome P450 sub-family: Transcriptional regulation, inter-individual variation and interaction networks. Biochimica et Biophysica Acta (BBA) - General Subjects 1770:3, pages 478-488.
Crossref
Crossref
Michal Otyepka, Josef Skopalík, Eva Anzenbacherová & Pavel Anzenbacher. (2007) What common structural features and variations of mammalian P450s are known to date?. Biochimica et Biophysica Acta (BBA) - General Subjects 1770:3, pages 376-389.
Crossref
Crossref
William J. Egan. 2007. Annual Reports in Medicinal Chemistry Volume 42. Annual Reports in Medicinal Chemistry Volume 42
449
467
.
D.R. Hawkins. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
795
807
.
P. Crivori & I. Poggesi. (2006) Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs. European Journal of Medicinal Chemistry 41:7, pages 795-808.
Crossref
Crossref
Peter Hlavica. (2006) Functional interaction of nitrogenous organic bases with cytochrome P450: A critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1764:4, pages 645-670.
Crossref
Crossref
James W Paxton, Philip Kestell, Daniel Chiang, Shufeng Zhou & David FV Lewis. (2005) INHIBITION OF HUMAN CYP1A2 OXIDATION OF 5,6‐DIMETHYL‐XANTHENONE‐4‐ACETIC ACID BY ACRIDINES: A MOLECULAR MODELLING STUDY. Clinical and Experimental Pharmacology and Physiology 32:8, pages 633-639.
Crossref
Crossref
Jan M. Kriegl, Thomas Arnhold, Bernd Beck & Thomas Fox. (2005) Prediction of Human Cytochrome P450 Inhibition Using Support Vector Machines. QSAR & Combinatorial Science 24:4, pages 491-502.
Crossref
Crossref